L’immunothérapie au service de la chimiothérapie, de nouvelles avancées
Authors:
- 1 April 2016
- journal article
- review article
- Published by EDP Sciences in médecine/sciences
- Vol. 32 (4) , 353-361
Abstract
In the last decade, a growing body of evidence has highlighted the major role of cancer immunosurveillance. The immune system can recognize tumor cells and keep them under check for long period of time, but is impeded by escape mechanisms induced by the tumor itself. Interestingly, the efficacy of chemotherapy has been shown to depend on the immune response, which in turn is potentiated by chemical agents, creating a positive feedback loop leading to long term tumor resistance. In this review, we summarize some mechanisms underlying the synergy between chemo- and immuno-therapy.Keywords
This publication has 49 references indexed in Scilit:
- CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon ChemotherapyCancer Research, 2014
- Cyclophosphamide treatment induces rejection of established P815 mastocytoma by enhancing CD4 priming and intratumoral infiltration of P1E/H‐2Kd‐specific CD8+ T cellsInternational Journal of Cancer, 2013
- Immunogenic Cell Death in Cancer TherapyAnnual Review of Immunology, 2013
- Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivoCancer Immunology, Immunotherapy, 2012
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune InfiltratesCancer Research, 2011
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2010
- A History of Cancer ChemotherapyCancer Research, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- T cell immune reconstitution following lymphodepletionSeminars in Immunology, 2007
- Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effectsCancer Biology & Therapy, 2007